33rd Annual Congress of the European Society of Gene and Cell Therapy (ESGCT 2026)
Biotech33rd Annual Congress of the European Society of Gene and Cell Therapy, co-organized with the German Society for Gene Therapy (DG-GT). Covers gene and cell therapy science from fundamental biology to clinical translation.
Topics
Conference themes
- AAV and lentiviral vector engineering
- CAR-T and engineered cell therapies
- Genome editing (CRISPR, base/prime editing)
- In vivo and ex vivo gene therapy
- Manufacturing and analytics for ATMPs
- Clinical trials and translational outcomes
- Regulatory and ethical aspects
Upcoming deadlines
| Deadline | Date | Status | |
|---|---|---|---|
| Late abstract Late breaking abstract submissions accepted until 25 July | Jul 25, 2026 | 41 days left | source → |
Registration & fees
Publication
Practical details
Format: In person; four-day congress with plenaries, parallel scientific sessions, workshops, posters and an exhibition at the Congress Center Hamburg (CCH).
Organizer: European Society of Gene & Cell Therapy (ESGCT) & German Society for Gene Therapy (DG-GT)
ESGCT the 33rd Annual Congress in Hamburg, October 27-30, 2026, in collaboration with DG-GT; COST/GenE-Humdi conference grants may support eligible students.
Where to stay
